Hytest Ltdis An International Company Based In Turkufinlandspecializing In The Development And Manufacturing Of Monoclonal Antibodies And Antigens For The In Vitro Diagnosticsivdindustrywith Over 30 Years Of Experiencehytest Is Recognized As A Market Leaderfocusing On High Quality Products And Continuous Innovation The Company Offers A Variety Of Immunological Reagents Essential For Laboratory Tests And Research Applicationsits Product Portfolio Includes Reagents For Cardiac Markersinfectious Diseasesmetabolic Syndromeand Inflammation Markershytest Also Supports Product Development With Comprehensive Technical Resourcesensuring Customers Have Access To Detailed Information And Scientific Insights Acquired By Summa Equity In 2018Hytest Is Positioned Strategically Within The Biotechnology Sectorthe Company Collaborates With Organizations Like Gubbe To Engage In Social Initiativesdemonstrating Its Commitment To Community Support
